Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Actual-world research characterize an necessary step within the medical analysis course of, Dr. Alexander Spira defined in an interview with CURE.“This part...
Most cancers throughout being pregnant is uncommon however more and more acknowledged as maternal age rises and non-invasive prenatal testing turns into...
